The Baker Institute is committed to scientific excellence and our ‘2020 Best of Baker Awards’ recognise outstanding research achievement based on scientific publications. They demonstrate areas where scientific discoveries are likely to have significant impact in health and medical research.
Our focus now is on translating this research to develop new drugs and devices, to inform policy, to develop best-practice prevention and treatment guidelines, and to facilitate education programs for healthcare professionals.
This is how our research is making a difference to the health of Australians, and people around the world.
- Transcatheter aortic valve implantation represents an anti-inflammatory therapy via reduction of shear stress-induced, piezo-1-mediated monocyte activation (Basic Science)
- Deficiency of prebiotic fiber and insufficient signaling through gut metabolite-sensing receptors leads to cardiovascular disease (Basic Science)
- Alcohol abstinence in drinkers with atrial fibrillation (Clinical/Epidemiology)
- Risk of rapid kidney function decline, all-cause mortality, and major cardiovascular events in nonalbuminuric chronic kidney disease in type 2 diabetes (Clinical/Epidemiology)
- High-resolution transcriptomic profiling of the heart during chronic stress reveals cellular drivers of cardiac fibrosis and hypertrophy
- Incidence of hospitalization for heart failure relative to major atherosclerotic events in type 2 diabetes: a meta-analysis of cardiovascular outcomes trials
- Neutrophil-derived S100A8/A9 amplify granulopoiesis after myocardial infarction
- The association between age of onset of type 2 diabetes and the long-term risk of end-stage kidney disease: a national registry study
- Alarmin-activated B cells accelerate murine atherosclerosis after myocardial infarction via plasma cell-immunoglobulin-dependent mechanisms
- Prediction of ventricular arrhythmias with left ventricular mechanical dispersion: a systematic review and meta-analysis
- Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients
- Association of asymptomatic diastolic dysfunction assessed by left atrial strain with incident heart failure